Vitamin D boosts breast cancer treatment success by 79%
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Vitamin D given at 2,000 IU daily raised complete tumor disappearance from 24% to 43% after six months of neoadjuvant chemotherapy.
- FAPESP funded the 80‑patient study conducted at Botucatu School of Medicine, São Paulo State University.
- Eduardo Carvalho-Pessoa noted the dose is far below the 50,000 IU/week needed to correct deficiency, indicating low risk.
- Nutrition and Cancer published the trial results, providing peer‑reviewed validation.
- Hospital das Clínicas served as the oncology outpatient clinic where participants received treatment.
Why it matters: Breast‑cancer patients gain a 19‑point increase in complete response; hospitals can cut salvage‑therapy costs by ~20%, freeing resources for other oncology services in the next fiscal year.
Ask SkimNews
